BRAENDER LORI J 4
4 · Aquestive Therapeutics, Inc. · Filed May 11, 2026
Research Summary
AI-generated summary of this filing
Aquestive (AQST) Corporate Secretary Lori Braender Sells 135,690 Shares
What Happened
Lori J. Braender, listed as Corporate Secretary (remarked as Former Chief Legal Officer and Chief Compliance Officer), had 135,690 shares withheld by the issuer to satisfy tax withholding related to vested restricted stock units (RSUs). The withholding occurred on 2026-05-07 at an effective price of $4.23 per share, totaling $573,969. This was a tax-withholding disposition (transaction code F), not an open-market sale.
Key Details
- Transaction date: 2026-05-07; Filing date (Form 4): 2026-05-11. The filing appears after the typical 2-business-day Form 4 window.
- Shares withheld/disposed: 135,690 shares at $4.23 per share; aggregate value $573,969.
- Shares owned after transaction: Not reported in the provided filing details.
- Footnote: F1 — shares were withheld by the issuer to satisfy the reporting person's tax withholding obligation in connection with RSU vesting.
- Transaction code: F (tax withholding on vested equity).
Context
This was a cashless-type disposition where the company withheld shares to cover taxes on vested RSUs — a routine administrative action and not a market sale signaling a change in insider sentiment. Such withholdings are common when equity awards vest and do not necessarily indicate buying or selling intent.
Insider Transaction Report
- Tax Payment
Common Stock
[F1]2026-05-07$4.23/sh−135,690$573,969→ 231,042 total
Footnotes (1)
- [F1]Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.